The HER2/neu (erbB2) polymorphism, body mass index, and the risk of endometrial cancer

被引：0
|
作者：
Lee, J.
Tong, S.
Lee, K.
Kim, J.
Kwon, Y.
Kim, J.
Kim, Y.
Yei, J.
Do, Y.
Kwon, S.
机构：
[1] Kyung Hee Univ, EW Neo Med Ctr, Seoul, South Korea
[2] Gachon Univ, Gil Med Ctr, Inchon, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
[4] Hallym Univ, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Seoul, South Korea
[6] Catholic Univ, Daegu Sch Med, Taegu, South Korea
[7] Keimyung Univ, Sch Med, Taegu, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22199
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The erbB2/HER2/neu receptor polymorphism IIe655Val and breast cancer
    Cox, DG
    Hankinson, SE
    Hunter, DJ
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 447 - 450
  • [2] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [3] Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)
    Reid, Alison
    Vidal, Laura
    Shaw, Heather
    de Bono, Johann
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 481 - 489
  • [4] ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor
    Alvarado, Diego
    Klein, Daryl E.
    Lemmon, Mark A.
    FASEB JOURNAL, 2009, 23
  • [5] TUMOR-SPECIFIC METHYLATION PATTERNS OF ERBB2 (HER2/NEU) SEQUENCES IN GASTROINTESTINAL CANCER
    HOLZMANN, K
    WELTER, C
    KLEIN, V
    PISTORIUS, G
    SEITZ, G
    BLIN, N
    ANTICANCER RESEARCH, 1992, 12 (03) : 1013 - 1018
  • [6] Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer
    Carmen Duran, M.
    Vega, Francisco
    Moreno-Bueno, Gema
    Jesus Artiga, M.
    Sanchez, Lydia
    Palacios, Jose
    Ridley, Anne
    Timms, John F.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (09) : 1313 - 1326
  • [7] The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein
    Li, HB
    Sánchez-Torres, J
    del Carpio, A
    Salas, V
    Villalobo, A
    BIOCHEMICAL JOURNAL, 2004, 381 : 257 - 266
  • [8] ERBB1/EGFR and ERBB2 (HER2/neu) - Targeted therapies in cancer and cardiovascular system with cardiovascular drugs
    Patane, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1301 - 1303
  • [9] Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
    Schroeder, Richard L.
    Stevens, Cheryl L.
    Sridhar, Jayalakshmi
    MOLECULES, 2014, 19 (09) : 15196 - 15212
  • [10] HER2/neu (erbB2) kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGF receptors
    Wang, Shizhen Emily
    Narasanna, Archana
    Perez-Torres, Marianela
    Xiang, Bin
    Dugger, Teresa C.
    Wu, Frederick Y.
    Yang, Seungchan
    Gazdar, Adi F.
    Muthuswamy, Senthil K.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2006, 66 (08)
12345